Literature DB >> 8523185

Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis.

L Donato1, H de la Salle, D Hanau, M M Tongio, M Oswald, A Vandevenne, J Geisert.   

Abstract

Two siblings with pansinusitis, nasal polyps, and bronchiectasis were found to have histocompatibility lymphocyte antigen (HLA) class I antigen deficiency ("bare lymphocyte syndrome") and dysfunction of natural killer cells. Reduced class I cell surface expression resulted from a single mutation in the TAP2 gene, which is located in the class II region of the major histocompatibility complex and encodes subunit 2 of the class I peptide transporter. The defect was transmitted in an autosomal recessive manner. This deficiency did not lead to severe viral infections but was apparently associated with susceptibility to bacterial infections of the respiratory mucosae. We suggest that class I HLA typing should be systematically performed in children with unexplained bronchiectasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8523185     DOI: 10.1016/s0022-3476(95)70024-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

Review 1.  TAP deficiency syndrome.

Authors:  S D Gadola; H T Moins-Teisserenc; J Trowsdale; W L Gross; V Cerundolo
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Immunity to microbes: lessons from primary immunodeficiencies.

Authors:  Magda Carneiro-Sampaio; Antonio Coutinho
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

3.  Unilateral necrotising toxoplasmic retinochoroiditis as the main clinical manifestation of a peptide transporter (TAP) deficiency.

Authors:  A Parissiadis; A Dormoy; D Fricker; D Hanau; H de la Salle; J-P Cazenave; P Lenoble; L Donato
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

4.  Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency.

Authors:  N Matamoros; J Milà; M Llano; A Balas; J L Vicario; J Pons; C Crespí; N Martinez; J Iglesias-Alzueta; M López-Botet
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

5.  Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.

Authors:  L Zhang; J S Pagano
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  A novel spontaneous mutation in the TAP2 gene unravels its role in macrophage survival.

Authors:  Antonio Lapenna; Ibrahim Omar; Michael Berger
Journal:  Immunology       Date:  2017-01-19       Impact factor: 7.397

7.  BPI-ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections.

Authors:  H Schultz; S Schinke; J Weiss; V Cerundolo; W L Gross; S Gadola
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

8.  Alessandro Moretta and Transporter Associated With Antigen Processing (TAP) Deficiency: On Giant's Shoulders.

Authors:  Jacques Zimmer
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

9.  The immune response and its therapeutic modulation in bronchiectasis.

Authors:  Massoud Daheshia; James D Prahl; Jacob J Carmichael; John S Parrish; Gilbert Seda
Journal:  Pulm Med       Date:  2012-10-10

10.  Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency.

Authors:  Jacques Zimmer; Huguette Bausinger; Emmanuel Andrès; Lionel Donato; Daniel Hanau; François Hentges; Alessandro Moretta; Henri de la Salle
Journal:  PLoS One       Date:  2007-10-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.